Strike Pharma is a Swedish biotech company with a proprietary technology for targeted LNP delivery, enabling personalized in vivo CAR therapies for autoimmune disease and cancer. Specifically, our affinity conjugation technology provides a solution for attachment of multiple LNPs to a targeting unit, as well as solutions to CMC challenges. In addition, it augments both potency and efficacy through the optimal orientation of targeting units.
Learn more about our Technology, Pipeline and Disease indications, and see our Publications and posters.